Nichi-Iko Pharmaceutical Co Ltd (4541.T)
16 Aug 2018
Latest Key Developments (Source: Significant Developments)
Nov 28 (Reuters) - Nichi-Iko Pharmaceutical Co Ltd <4541.T>:Says it will start sales of Infliximab BS for I.V. Infusion 100mg "Nichi-Iko" on Nov. 29. Full Article
Nichi-Iko Pharmaceutical Co Ltd <4541.T>:Says it completed full acquisition of Sagent Pharmaceuticals, Inc.
* Says it will apply International Financial Reporting Standards (IFRS) as the new accounting method, to replace the current Japanese Generally Accepted Accounting Principles